Hanmi Science Co., Ltd(KR:008930)
â‚©52,400.00-2000.00 (-3.68%)
KR:008930
Hanmi Science Co., Ltd financials statements
â‚©52,400.00
At close:-2000.00 (-3.68%)
Want to see KR:008930 full AI Analyst Report?
Hanmi Science Co., Ltd (008930) Ratios
Hanmi Science Co., Ltd Ratios
KR:008930's free cash flow for Q3 2026 was ₩4.44B. For the 2026 fiscal year, KR:008930's free cash flow was decreased by ₩-4.35B and operating cash flow was ₩8.79B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.80 | 0.70 | 0.69 | 0.71 | 1.01 |
| Quick Ratio | 0.55 | 0.47 | 0.43 | 0.38 | 0.53 |
| Cash Ratio | 0.27 | 0.18 | 0.07 | 0.06 | 0.08 |
| Solvency Ratio | 0.24 | 0.14 | 0.28 | 0.19 | 0.19 |
| Operating Cash Flow Ratio | 0.10 | 0.18 | 0.09 | 0.03 | 0.06 |
| Short-Term Operating Cash Flow Coverage | 0.21 | 0.39 | 0.17 | 0.05 | 0.25 |
| Net Current Asset Value | â‚© -141.74B | â‚© -182.41B | â‚© -164.80B | â‚© -139.59B | â‚© -37.04B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.16 | 0.17 | 0.18 | 0.06 |
| Debt-to-Equity Ratio | 0.23 | 0.26 | 0.27 | 0.28 | 0.08 |
| Debt-to-Capital Ratio | 0.19 | 0.21 | 0.21 | 0.22 | 0.08 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Financial Leverage Ratio | 1.54 | 1.60 | 1.56 | 1.53 | 1.38 |
| Debt Service Coverage Ratio | 0.22 | 0.34 | 0.31 | 0.20 | 0.49 |
| Interest Coverage Ratio | 5.42 | 8.71 | 12.25 | 7.52 | 16.03 |
| Debt to Market Cap | 0.09 | 0.11 | 0.08 | 0.09 | 0.02 |
| Interest Debt Per Share | 3491.53 | 3377.36 | 3294.73 | 3003.80 | 849.45 |
| Net Debt to EBITDA | 1.50 | 1.57 | 2.27 | 4.22 | 1.17 |
| Profitability Margins | |||||
| Gross Profit Margin | 20.06% | 21.24% | 21.24% | 9.72% | 100.00% |
| EBIT Margin | 4.20% | 5.80% | 5.87% | 3.57% | 3.03% |
| EBITDA Margin | 4.90% | 6.56% | 6.57% | 4.09% | 3.58% |
| Operating Profit Margin | 4.20% | 7.70% | 9.97% | 2.69% | 3.03% |
| Pretax Profit Margin | 9.80% | 4.92% | 10.46% | 7.00% | 5.17% |
| Net Profit Margin | 8.72% | 4.63% | 9.23% | 6.62% | 4.52% |
| Continuous Operations Profit Margin | 8.68% | 4.42% | 9.23% | 6.60% | 4.52% |
| Net Income Per EBT | 89.06% | 94.18% | 88.19% | 94.57% | 87.42% |
| EBT Per EBIT | 233.32% | 63.82% | 104.88% | 260.32% | 170.84% |
| Return on Assets (ROA) | 7.94% | 4.40% | 9.39% | 6.24% | 4.52% |
| Return on Equity (ROE) | 12.25% | 7.07% | 14.62% | 9.55% | 6.22% |
| Return on Capital Employed (ROCE) | 5.64% | 11.23% | 14.98% | 3.69% | 3.94% |
| Return on Invested Capital (ROIC) | 4.07% | 8.10% | 10.62% | 2.77% | 3.20% |
| Return on Tangible Assets | 8.23% | 4.59% | 9.93% | 6.35% | 4.56% |
| Earnings Yield | 4.80% | 2.98% | 4.32% | 3.19% | 1.18% |
| Efficiency Ratios | |||||
| Receivables Turnover | 12.73 | 12.44 | 11.48 | 9.52 | 9.52 |
| Payables Turnover | 9.30 | 9.05 | 16.42 | 11.40 | 0.02 |
| Inventory Turnover | 8.85 | 9.30 | 9.37 | 7.88 | 0.02 |
| Fixed Asset Turnover | 12.43 | 12.79 | 13.27 | 11.76 | 36.48 |
| Asset Turnover | 0.91 | 0.95 | 1.02 | 0.94 | 1.00 |
| Working Capital Turnover Ratio | -11.51 | -9.79 | -11.16 | -20.75 | -673.35 |
| Cash Conversion Cycle | 30.65 | 28.25 | 48.51 | 52.65 | 344.44 |
| Days of Sales Outstanding | 28.67 | 29.34 | 31.79 | 38.34 | 38.34 |
| Days of Inventory Outstanding | 41.24 | 39.26 | 38.95 | 46.34 | 23113.72 |
| Days of Payables Outstanding | 39.26 | 40.35 | 22.22 | 32.02 | 22807.63 |
| Operating Cycle | 69.91 | 68.60 | 70.74 | 84.68 | 23152.06 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 702.04 | 1225.52 | 517.37 | 137.99 | 199.50 |
| Free Cash Flow Per Share | 422.33 | 1053.65 | 389.67 | 16.20 | 167.23 |
| Dividend Paid and CapEx Coverage Ratio | 1.47 | 2.60 | 1.60 | 0.44 | 0.90 |
| Capital Expenditure Coverage Ratio | 2.51 | 7.13 | 4.05 | 1.13 | 6.18 |
| Operating Cash Flow Coverage Ratio | 0.21 | 0.38 | 0.16 | 0.05 | 0.24 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.06 | 0.03 | 0.01 | 0.01 |
| Free Cash Flow Yield | 1.17% | 3.58% | 0.99% | 0.05% | 0.31% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 20.74 | 33.54 | 23.14 | 31.32 | 84.91 |
| Price-to-Sales (P/S) Ratio | 1.82 | 1.55 | 2.13 | 2.07 | 3.84 |
| Price-to-Book (P/B) Ratio | 2.55 | 2.37 | 3.38 | 2.99 | 5.28 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 85.83 | 27.95 | 100.60 | 1954.23 | 317.75 |
| Price-to-Operating Cash Flow Ratio | 51.64 | 24.03 | 75.77 | 229.36 | 266.35 |
| Price-to-Earnings Growth (PEG) Ratio | 0.21 | -0.70 | 0.34 | 0.51 | 0.94 |
| Enterprise Value Multiple | 38.60 | 25.27 | 34.77 | 54.83 | 108.39 |
| Enterprise Value | 2.56T | 2.13T | 2.85T | 2.35T | 3.69T |
| EV to EBITDA | 38.60 | 25.27 | 34.77 | 54.83 | 108.39 |
| EV to Sales | 1.89 | 1.66 | 2.28 | 2.25 | 3.88 |
| EV to Free Cash Flow | 89.30 | 29.80 | 107.63 | 2117.01 | 321.22 |
| EV to Operating Cash Flow | 53.72 | 25.62 | 81.06 | 248.47 | 269.26 |
| Tangible Book Value Per Share | 13392.76 | 11580.36 | 10600.01 | 10301.94 | 9949.31 |
| Shareholders’ Equity Per Share | 14206.40 | 12418.65 | 11588.48 | 10581.16 | 10059.87 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.12 | 0.10 | 0.12 | 0.06 | 0.13 |
| Revenue Per Share | 19950.42 | 18953.44 | 18363.45 | 15272.20 | 13846.96 |
| Net Income Per Share | 1740.45 | 877.53 | 1694.06 | 1010.45 | 625.80 |
| Tax Burden | 0.89 | 0.94 | 0.88 | 0.95 | 0.87 |
| Interest Burden | 2.33 | 0.85 | 1.78 | 1.96 | 1.71 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.10 | 0.10 | 0.09 | 0.91 | 0.92 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.41 | 1.46 | 0.31 | 0.14 | 0.32 |
Currency in KRW

